125 related articles for article (PubMed ID: 14557670)
1. Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy.
Tam PE; Weber-Sanders ML; Messner RP
J Virol; 2003 Nov; 77(21):11849-54. PubMed ID: 14557670
[TBL] [Abstract][Full Text] [Related]
2. Interactions between multiple genetic determinants in the 5' UTR and VP1 capsid control pathogenesis of chronic post-viral myopathy caused by coxsackievirus B1.
Sandager MM; Nugent JL; Schulz WL; Messner RP; Tam PE
Virology; 2008 Mar; 372(1):35-47. PubMed ID: 18029287
[TBL] [Abstract][Full Text] [Related]
3. Coxsackievirus B1-induced chronic inflammatory myopathy: differences in induction of autoantibodies to muscle and nuclear antigens by cloned myopathic and amyopathic viruses.
Tam PE; Fontana DR; Messner RP
J Lab Clin Med; 2003 Sep; 142(3):196-204. PubMed ID: 14532908
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus-induced chronic inflammatory myopathy: virus variants distinguish between acute cytopathic effects and pathogenesis of chronic disease.
Tam PE; Messner RP
Virology; 1997 Jun; 233(1):199-209. PubMed ID: 9201230
[TBL] [Abstract][Full Text] [Related]
5. Genetic determinants of susceptibility to coxsackievirus B1-induced chronic inflammatory myopathy: effects of host background and major histocompatibility complex genes.
Tam PE; Messner RP
J Lab Clin Med; 1996 Sep; 128(3):279-89. PubMed ID: 8783635
[TBL] [Abstract][Full Text] [Related]
6. Molecular determinants for virulence in coxsackievirus B1 infection.
Rinehart JE; Gómez RM; Roos RP
J Virol; 1997 May; 71(5):3986-91. PubMed ID: 9094675
[TBL] [Abstract][Full Text] [Related]
7. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype.
Caggana M; Chan P; Ramsingh A
J Virol; 1993 Aug; 67(8):4797-803. PubMed ID: 8392614
[TBL] [Abstract][Full Text] [Related]
8. Predominant right leg dysfunction without asymmetric muscle inflammation in CD1 Swiss mice with coxsackievirus B1-induced myositis.
Jongen PJ; Eling P; Van de Putte LB
Physiol Behav; 1996; 59(4-5):763-8. PubMed ID: 8778864
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution.
Tam PE; Messner RP
J Virol; 1999 Dec; 73(12):10113-21. PubMed ID: 10559326
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and genetic changes in coxsackievirus B5 following repeated passage in mouse pancreas in vivo.
Al-Hello H; Davydova B; Smura T; Kaialainen S; Ylipaasto P; Saario E; Hovi T; Rieder E; Roivainen M
J Med Virol; 2005 Apr; 75(4):566-74. PubMed ID: 15714484
[TBL] [Abstract][Full Text] [Related]
11. Mutations at nucleotides 573 and 579 within 5'-untranslated region augment the virulence of coxsackievirus B1.
Zhong Z; Li X; Zhao W; Tong L; Liu J; Wu S; Lin L; Zhang Z; Tian Y; Zhang F
Virus Res; 2008 Aug; 135(2):255-9. PubMed ID: 18514346
[TBL] [Abstract][Full Text] [Related]
12. T cells are required for coxsackievirus B1 induced murine polymyositis.
Ytterberg SR; Mahowald ML; Messner RP
J Rheumatol; 1988 Mar; 15(3):475-8. PubMed ID: 2837572
[TBL] [Abstract][Full Text] [Related]
13. Importance of arginine 20 of the swine vesicular disease virus 2A protease for activity and virulence.
Inoue T; Alexandersen S; Clark AT; Murphy C; Quan M; Reid SM; Sakoda Y; Johns HL; Belsham GJ
J Virol; 2005 Jan; 79(1):428-40. PubMed ID: 15596836
[TBL] [Abstract][Full Text] [Related]
14. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1.
Zaini Z; Phuektes P; McMinn P
Virus Res; 2012 Jul; 167(1):86-96. PubMed ID: 22575826
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate sequences that determine virulence in Coxsackievirus B4.
Ramsingh A; Araki H; Bryant S; Hixson A
Virus Res; 1992 May; 23(3):281-92. PubMed ID: 1320798
[TBL] [Abstract][Full Text] [Related]
16. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
[TBL] [Abstract][Full Text] [Related]
17. Coxsackievirus B1-induced murine myositis: no evidence for viral persistence.
Zoll J; Jongen P; Galama J; van Kuppeveld F; Melchers W
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2071-6. PubMed ID: 8409931
[TBL] [Abstract][Full Text] [Related]
18. Mapping of tissue tropism determinants in coxsackievirus genomes.
Harvala H; Kalimo H; Dahllund L; Santti J; Hughes P; Hyypiä T; Stanway G
J Gen Virol; 2002 Jul; 83(Pt 7):1697-1706. PubMed ID: 12075089
[TBL] [Abstract][Full Text] [Related]
19. Tissue tropism of recombinant coxsackieviruses in an adult mouse model.
Harvala H; Kalimo H; Bergelson J; Stanway G; Hyypiä T
J Gen Virol; 2005 Jul; 86(Pt 7):1897-1907. PubMed ID: 15958668
[TBL] [Abstract][Full Text] [Related]
20. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication.
Seo I; Jee Y; Ahn J; Jun EJ; Kim D; Joo CH; Kim YK; Lee H
Intervirology; 2007; 50(6):447-53. PubMed ID: 18268408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
